SCHEMBL6568494

SCHEMBL6568494

CCCc1[c]cccc1-c1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.44
ABCB1 P08183 1/20 0.44
BCR P11274 1/20 0.44
MAPT P10636 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
PTGS2 P35354 1/20 0.38
CRHR1 P34998 1/20 0.37
SYK P43405 1/20 0.37
AURKB Q96GD4 1/20 0.37
INCENP Q9NQS7 1/20 0.37
MAOB P27338 2/20 0.37
BACE1 P56817 1/20 0.36
DRD2 P14416 1/20 0.36
PTPN1 P18031 1/20 0.36
PPARG P37231 2/20 0.35
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35
QPCT Q16769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8913079 0.87 ABL1 (0.46) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL6736553 0.83 ABL1 (0.45) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL457404 0.82 SMN1; SMN2 (0.36) MAPTPTGS2HTR7
SCHEMBL17646448 0.81 PPARG (0.34) MAPTPPARG
SCHEMBL8477965 0.80 MAPT (0.39) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL10700335 0.75 ABL1 (0.44) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL1646823 0.75 ABL1 (0.50) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL4561266 0.75 ABL1 (0.50) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL1867724 0.75 ABL1 (0.50) ABL1ABCB1BCRMAPTHDAC4
SCHEMBL1646811 0.75 ABL1 (0.50) ABL1ABCB1BCRMAPTHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404325-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2004-04-07 EP disclosed
WO-2002096420-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2002-12-05 WO disclosed
EP-1127049-A1 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL Holdings, Inc. (US) 2001-08-29 EP disclosed
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-2000016603-A2 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL HOLDINGS, INC. (US) 2000-03-30 WO disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed